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Materials/Methods: In our hospital, the treatment plans made mostly by
radiation oncologists are checked by two medical physicists using a chart
check implemented in an electronic health record system. If the physicist
detects the errors in TPS-stage, the detector completes the near-incident and
incident report, and these reports are submitted to monthly radiation safety
conference. All of the staffs involved in radiation therapy attend the
conference and information of the new errors and the possible counter-
measureswill be informed to all the staffs. The 5513 treatment plans between
May 2007 and December 2011 were checked before the treatments.
Results: Of the 5513 treatment plans, all of the 376 errors were detected
before the actual delivery of irradiation. Average error probability of 7%was
obtained. That means that, approximately 7 out of 100 treatment plans have
something wrong in the TPS-stage: Table shows the errors with a higher
probability. “MLC/Jaw” is one relating to mis-setting the field size with
the collimator jaws and multi-leaf collimators (MLC). “Dose/fraction” is
one relating to mis-setting dose and fraction, e.g., prescribed dose is not
equal to the sum of dose of each field. “Isocenter/Reference point” is one
relating to mis-locations of isocenter and reference point (not ICRU
prescription, etc). Some examples of countermeasures are the feedback of
these results to the planner to prevent the errors, the training for the staffs,
and the utilizing manual describing the pit-falls in the operation of the TPS.Poster Viewing Abstract 3456; Table Classification of the 372 errors in
5513 treatment plans
Error Probability Number of events
Jaw/MLC 1.5% 83
Machine ID 1.2% 65
Dose/fraction 0.9% 49
Isocenter/Reference point 0.8% 42
Bolus 0.2% 12
Algorithm 0.2% 11
Heterogeneity correction 0.2% 10
Others 1.8% 100
Total 6.7% 372Conclusion: It is more important to establish the system of completely
detecting the unexpected errors by “Robust QA program”. The errors in
the TPS-stage should be shared with not only the radiation oncologists as
planners, but also with medical physicists and radiation technologists, and
the other staffs involved in radiation therapy, which lead to create “safety
culture” in the department.
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The Application of Metal Artifact Reduction Algorithm in CT
Spectral Imaging on Radiation Therapy Dose Calculation
H. Geng, S. Yu, K. Cheung, W. Lam, and S.G. Lo; Hong Kong Sanatorium
& Hospital, Hong Kong, Hong Kong
Purpose/Objective(s): To evaluated the effect of applying metal artifact
reduction technique using CT spectral imaging on radiation therapy dose
calculation.
Materials/Methods: A cylindrical phantom (20cm long with 15cm
diameter) implanted with four stainless steel inserts (4.5cm long with
0.4cm diameter) was used in this study. The inserts were positioned
symmetrically 1.5cm from the central axis of the phantom. The phantom
with metallic inserts was scanned on a dual-energy CT scanner using both
conventional 120kVp technique and spectral imaging technique. 140keV
monochromatic images applied with metal artifact reduction algorithm
were also reconstructed. The variation of CT number in central region of
the phantom surrounded by the metallic inserts was assessed for both
image sets. As standard for comparison, an artifact-free image set was
created by scanning the phantom without metallic inserts using 120kVp
technique and assigning the density of stainless steel to the inserts’locations on the phantom images. A cylindrical target volume (3cm long
with 2cm diameter) was defined in the center of the phantom. A volumetric
modulated arc therapy plan was generated on the artifact-free images. The
same plan was copied and applied to both 120kVp images and 140keV
monochromatic images. Dose differences calculated from different images
were evaluated and compared with the actual dose measurements using an
ionization chamber and radiochromic film.
Results: Serious metallic artifacts were observed in the 120kVp images,
with CT numbers in the central region of the phantom varied from
-1000HU to 766HU (mean Z 14.6HU, SD Z 459.6). The metallic arti-
facts were significantly reduced in the 140keV images, with CT numbers
varied from 126HU to 171HU (mean Z 152.4HU, SD Z 8.9). These
variations in CT number contributed to the variation in relative electron
density from 0 to 1.44 and from 1.12 to 1.16, respectively, whereas the
expected electron density was 1.11 as measured in the standard artifact-
free images. Comparing to radiochromic film measurement, the dose
distributions calculated using these three image sets were all within 3%/
3mm tolerance in gamma analysis. The deviations between measured and
calculated dose using three image sets were all less than 1%.
Conclusions: The metal artifact reduction algorithm in CT spectral
imaging technique can significantly reduce the metallic artifacts, which
may help to improve the accuracy in dose calculation and delineation of
tumors and critical structures. But for small objects, the improvement in
dosimetric accuracy was not significant.
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Dosimetric Evaluation of the Interplay Between LINAC Movement
and Tumor Motion in Respiratory Gated VMAT of Lung Cancer
C. Ng, V.H. Lee, and T. Leung; Queen Mary Hospital, Hong Kong,
Hong Kong
Purpose/Objective(s): Respiratory gated radiation therapy of lung cancer
helps to minimize the treated volume and hence treatment side effects.
VMAT can reduce the treatment time while producing a highly conformed
dose distribution. However, in gated VMAT delivery, the interplay effect
between the LINAC movement (MLC and gantry) and tumor motion may
result in undesirable hot and cold spots jeopardizing tumor coverage. In
this study we investigated the possible dosimetric errors caused by the
interplay between the tumor motion and the LINAC movement for gated
VMAT lung cancer treatment.
Materials/Methods: We studied 2 lung cancer cases prescribed to 60 Gy
given in 30 fractions. GTVs were contoured on each of the 10 phases of
4DCT. The end-expiration phase and 3 neighboring phases were chosen for
gating (40%-70%). The GTVgating consisted of the volume encompassing
GTVs of the 4 phases. 5 mmmargin was added to the GTVgating to create the
CTVgating and 8 mm margin was added to generate the PTVgating. A highly
modulated single arcVMATplanwas derived for each case based on the 50%
phase image. The plans aimed to minimize dose to the spinal cord while
maintaining PTV coverage. A programwas written to segment the arc in the
original plan with 177 control points into 88 mini arcs with 3 control points
each. Eachmini arc spanned about 0.67 second and was assumed to irradiate
1 phase of the gating window during which there should be relatively little
movement of the anatomy. Every one in four arcs was then inserted into
a VMAT plan irradiating each of the 4 phases, thus generating 4 plans each
having 22 mini arcs. Dose calculation was done for each plan on the CT
image for the particular phase. The resulting dose from each plan was then
mapped to the base phase image (50%) and finally summed with a deform-
able dose accumulation software. The resulting dose was compared to the
original dose distribution.
Results: See Table.
Conclusion: The dosimetric effect of the interplay between tumor motion
and LINAC movement was studied for 2 lung cancer cases. It was found
that there was no significant difference in tumor coverage when the orig-
inal plan was done assuming a static target. The dose to critical structures
also remained very close to the original plan. It can be concluded that
Poster Viewing Abstract 3458; Table Summary of dosimetric results
Plan
PTV vol
(cc)
PTV D95%
(Gy)
PTV D1%
(Gy)
Mean
lung dose
(Gy)
Spinal
cord D1%
(Gy)
Case 1 VMAT 254.8 60.0 65.7 19.2 41.6
Sum 4
Phase
Plan
254.8 59.7 66.0 19.3 41.0
Case 2 VMAT 22.7 60.6 63.9 7.0 7.0
Sum 4
Phase
Plan
22.7 60.1 63.9 7.0 7.3
Volume 84  Number 3S  Supplement 2012 Poster Viewing Abstracts S767interplay between LINAC movement and tumor motion will not affect the
dosimetric quality of gated VMAT plans for lung cancer.
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MVCT-Detector-based Dose Reconstruction Makes Phantom QA
Measurements for Tomotherapy Prostate Treatments Redundant
T. Nuver, D. Kramer, V. Althof, R. Westendorp, and A. Minken; RISO,
Deventer, Netherlands
Purpose/Objective(s): (1) To reconstruct delivered dose for prostate
patients treated on a tomotherapy unit based on measurements with the
integrated MVCT-detector array. (2) To report the first clinical experiences
using first fraction dose reconstruction instead of pre-treatment phantom
measurements.
Materials/Methods: Dose verification software tools were used to compare
reconstructed delivered dose with planned dose. Fractionation schedules
varied from 2.3 to 2.9 Gy, depending on tumor stage. Treatment plans were
generated on two versions of tomotherapy TPS (69 patients [version 1]
and13 patients [version 2], respectively). All patients were positioned based
on daily, on-line MVCT scans using implanted gold markers. The detector
signals were attenuation corrected based on the planning kVCT scan to
reconstruct the incoming fluence. This fluence was then re-projected on the
kVCT scan to calculate delivered dose. The planned dose distribution was
subtracted from the reconstructed distribution. Histograms were con-
structed from the local dose differences. Only voxels with a planned dose
larger than 80% of the prescribed fraction dose were considered.
Results: For 64 of the 82 patients all local dose differences were smaller than
5% of the prescribed dose. For 3 patients local dose differences larger than
10% were encountered. The largest dose differences were seen for patients
with considerable variations in the amount of gas in their rectum. Other
sources of deviations were patient positioning, hip prostheses, and machine
output drop at the end of target life. The introduction of GPU based compu-
tation for the dose verification software reduced the calculation time from two
hours inversion1 to twominutes inversion2. SinceNovember 2011 treatment
delivery for prostate patients is only checked by dose reconstruction. Phantom
measurements are initiated when large deviations (>6.5% of the prescribed
dose) are seen. For 5 out of 27 patients additional phantom measurements
were performed, which did not reveal any significant deviations.
Conclusion: Dose reconstruction based on MVCT-detector data yields
good agreement with the planned dose distribution. Phantom measure-
ments can be replaced by dose reconstruction, reducing the amount of QA
time on the treatment machine. With GPU-based computation, and further
development of deformable registration, accurate, on-line dose accumu-
lation may be achievable in the next years.
Author Disclosure: T. Nuver: None. D. Kramer: None. V. Althof: None.
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Automatic Adaptive Inverse Planning Optimization for
Head-and-Neck Cancer Radiation Therapy
X. Jiang,1,2 J. Liang,2 and Y. Di2; 1Department of Radiation Oncology,
West China Hospital, Sichuan University, Chengdu, China, 2Department of
Radiation Oncology, William Beaumont Hospital, Royal Oak, MIPurpose/Objective(s): Weekly offline adaptive inverse planning optimi-
zation needs to be performed during the H&N cancer adaptive radiation
therapy. To reduced clinical load, as well as improving planning reliability,
we developed an automatic adaptive inverse planningmethod, and evaluated
this method retrospectively by comparing it to the manual adaptive inverse
planning.
Materials/Methods: An iterative method was developed for the adaptive
inverse planning automation. The expected treatment dose in organs of
interest constructedusing theprevious andongoing treatment plans, and daily
CBCT images was utilized to setup an initial criteria for each organ in the
objective function. Following the initial inverse planning optimization, the
achieved objective value was used to modify the previous criteria in the
objectivewith respect to a pre-determined formulation, and thena new inverse
planning optimization was repeated accordingly. The iteration was stopped if
there was no clear improvement in the objective. The automatic planning
method was evaluated using the pre-treatment planning CT and daily CBCT
images obtained during the entire treatment course of 10 H&N cancer
patients. The evaluation was performed by comparing the total cumulative
treatment dose in all organs of interest constructed using the automatic plan
and a manual plan respectively. The manual adaptive inverse planning was
performed by a single person following a fixed rule on selecting the objective
criteria, with the goal to reduce a 5% from the currently achievable normal
organ dose-volume parameter obtained from the expected treatment dose.
Results: The adaptive planning was automatically completed for 30% of
cases with the average 8 iterations per case. Minor manual adjustment on
the target coverage was needed for the other 70% planning. Compared to
the treatment dose obtained from the pre-treatment IMRT plan, the mean
EUD to cord, brainstem, right parotid, left parotid and mandible with
respect to the automatic adaptive plan and the manual adaptive plan
decreased 36.0% (0.1%w48.3%) vs 9.1% (3.6%w17.2%); 45.4%
(31.4w54.3%) vs 10.2% (2.9%w19.3%); 23% (8.6%w33.8%) vs 12.4%
(3.1%w23.2%); 33.5% (24.3%w50.1%) vs 18.5% (7.6w23.3%); and
8.9% (2.5%w12.5%) vs 9.3% (2.0%w14.1%) respectively.
Conclusion: Our study demonstrated adaptive inverse planning can most
likely be performed automatically in clinical implementation. The quality
of the automatic planning is commonly superior to the manual planning if
“try-n-error” is not thoroughly applied in the manual planning process.
Author Disclosure: X. jiang: None. J. Liang: None. Y. Di: None.3461
Dose-Mass-based Inverse Optimization for Head-and-Neck Cancers
I.B. Mihaylov,1 I.B. Mihaylov,1 and E. Moros2; 1Rhode Island Hospital,
Providence, RI, 2Moffitt Cancer Center, Tampa, FL
Purpose/Objective(s): It has been argued in the literature that dose-mass-
histograms (Dmhs) may be more relevant to radiation therapy than
commonly accepted dose-volume-histograms (Dvhs). The widespread use
of Dvhs stems from thewealth of clinical information expressed in that form.
Furthermore, historically when the Dvhs were introduced the homogenous
dose calculations and optimizations were the norm, and thereby no attention
was paid to Dmhs. The purpose of this work is to compare Dvh and Dmh
inverse optimization results for head-and-neck (HN) cancer.
Materials/Methods: Ten HN patient plans were retrospectively optimized
for IMRT. The optimization was performed with Dmh and Dvh based
quadratic objective functions. With either optimization nine equally spaced
beams were used. Step-and-shoot IMRT with total of 100 segments was
used in each plan. The minimum allowed segment area and minimum
monitor units (MUs) per segment were set the same for Dmh and Dvh
optimization schemes. Both Dmh and Dvh plans were normalized such
that 95% of the PTV received the prescription dose. Once prescription was
achieved, the doses to organs at risk (OARs) such as spinal cord, brain-
stem, larynx, left and right parotid glands (OARs) were iteratively lowered
until standard deviation of the dose across the PTV in each plan becamew
4%. Dose indices (DIs), such as DPTV95% (dose to 95% of the PTV), D
Cord
1% ,
DBrainstem1% , D
Larynx
50% , D
Lt_parotid
50% , and D
Rt_parotid
50% were compared. Percent
difference between Dvh- and Dmh-plan derived dose indices were tallied,
with the Dmh-derived values used as reference. Therefore, if a DI
